ES2017032A6 - 4,5-dihydro-3(2h)-pyridazinones, process for producing them and their use - Google Patents

4,5-dihydro-3(2h)-pyridazinones, process for producing them and their use

Info

Publication number
ES2017032A6
ES2017032A6 ES8902791A ES8902791A ES2017032A6 ES 2017032 A6 ES2017032 A6 ES 2017032A6 ES 8902791 A ES8902791 A ES 8902791A ES 8902791 A ES8902791 A ES 8902791A ES 2017032 A6 ES2017032 A6 ES 2017032A6
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
alkyl moiety
residue
imidazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES8902791A
Other languages
Spanish (es)
Inventor
Gerhard Zoller
Rudi Beyerle
Melitta Just
Helmut Bohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella AG
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG, Cassella Farbwerke Mainkur AG filed Critical Cassella AG
Publication of ES2017032A6 publication Critical patent/ES2017032A6/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

4,5-Dihydro-3(2H)-pyridazinones of general formula (I), wherein R denotes hydrogen, alkyl with 1 to 3 carbon atoms or hydroxymethyl and R<1> denotes a phenyl residue of formula (II) or an indolyl residue of formula (III), R<2> being pyridyl, thiazolyl, imidazolyl, linked via an oxygen, nitrogen or sulphur atom or via a sulfinyl or sulfonyl group with the phenyl or indolyl residue, or imidazolyl, in which the thiazolyl and imidazolyl residues can possibly be substituted by alkyl with 1 to 3 carbon atoms, halogen, nitro, amino, alkylcarbonylamino with 1 to 3 carbon atoms in the alkyl moiety, mono- or dialkylamino with 1 to 3 carbon atoms per alkyl moiety or alkoxycarbonylamino with 1 to 3 carbon atoms in the alkyl moiety, R<3> being hydrogen, alkyl with 1 to 4 carbon atoms, alkoxy with 1 to 4 carbon atoms, hydroxy or halogen, and R<4> being hydrogen, alkyl with 1 to 5 carbon atoms, alkylcarbonyl with 1 to 4 carbon atoms in the alkyl moiety, phenylcarbonyl, alkoxycarbonyl with 1 to 4 carbon atoms in the alkyl moiety or phenalkoxycarbonyl with 1 to 4 carbon atoms in the alkyl moiety, as well as their producible, pharmaceutically acceptable acid addition salts, in which when R<1> is a phenyl residue, R<2> cannot be a pyridyl or imidazolyl residue linked via a nitrogen atom, are useful pharmacological active ingredients.
ES8902791A 1988-08-06 1989-08-04 4,5-dihydro-3(2h)-pyridazinones, process for producing them and their use Expired - Fee Related ES2017032A6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3826855A DE3826855A1 (en) 1988-08-06 1988-08-06 4,5-DIHYDRO-3 (2H) -PYRIDAZINONE, PROCESS FOR THEIR PREPARATION AND THEIR USE

Publications (1)

Publication Number Publication Date
ES2017032A6 true ES2017032A6 (en) 1990-12-16

Family

ID=6360424

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8902791A Expired - Fee Related ES2017032A6 (en) 1988-08-06 1989-08-04 4,5-dihydro-3(2h)-pyridazinones, process for producing them and their use

Country Status (4)

Country Link
KR (1) KR900701777A (en)
DE (1) DE3826855A1 (en)
ES (1) ES2017032A6 (en)
WO (1) WO1990001479A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007277163B2 (en) 2006-07-25 2012-06-21 Cephalon, Inc. Pyridizinone derivatives
CU24334B1 (en) * 2013-06-27 2018-04-03 Pfizer PIRIDIN-2 CONTAINING IL-4-SUBSTITUTED DERIVATIVES OF 1-DIAZINO PHENYL USEFUL AS LEGANDOS OF DOPAMINE
CN110117257B (en) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 P2Y12 receptor antagonist containing guanidyl as well as preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
DE3212304A1 (en) * 1982-04-02 1983-10-06 Nattermann A & Cie IMIDAZOLYLPHENYL-TETRAHYDROPYRIDAZINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
US4717730A (en) * 1982-12-03 1988-01-05 Warner-Lambert Company 4,5-dihydro-6-(substituted)phenyl-5-methyl-3-(2H)-pyridazinones and pharmaceutical compositions containing the compounds as active components
HU193067B (en) * 1983-12-14 1987-08-28 Mitsubishi Chem Ind Process for the production of new pyridazinon-derivatives and of their salts
AU5428686A (en) * 1985-03-12 1986-09-18 Smith Kline & French Laboratories Limited Imidazolinone and thiazolinone derivatives
DE3531658A1 (en) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh HETEROCYCLICALLY SUBSTITUTED INDOLE, INTERMEDIATE PRODUCTS, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
DE3826855A1 (en) 1990-02-15
KR900701777A (en) 1990-12-04
WO1990001479A1 (en) 1990-02-22

Similar Documents

Publication Publication Date Title
NZ507735A (en) Indole derivatives useful for treating malignant and other diseases caused by pathological cell proliferation
CA2247443A1 (en) Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
CA2250840A1 (en) Antivirally active heterocyclic azahexane derivatives
MY110226A (en) Therapeutic heterocyclic compounds.
GR851039B (en)
EP0383919A4 (en) Staurosporin derivatives
PH25906A (en) Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)azabicycloalkanes
HU9301155D0 (en) Methods for producing steroide derivatives and for their application in medical treatment
PH25859A (en) Composition for treatment of ischemic disorder
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
AU2177997A (en) Anticachectic composition
MY101042A (en) Pyridazinone derivatives,process for preparation thereof, and insecticidal compotions
ES2017032A6 (en) 4,5-dihydro-3(2h)-pyridazinones, process for producing them and their use
MY106985A (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis.
CA2247946A1 (en) Anticachectic composition
CA2073633A1 (en) Use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
TR199902019T2 (en) �kame edilmi� thiazolidion&#39; un haz�rlanmas� i�in proses.
ES2000125A6 (en) 5-Substituted-6-aminopyrimidine derivatives, composition and uses.
HK1043784A1 (en) Processes for preparing pesticidal intermediates.
PL222294A1 (en)
IL113414A0 (en) Methyl alpha -phenylbutenoates their preparation and use
AP1518A (en) Novel octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid derivatives, preparation method and use for preparing therapeutically active compounds.
ES2011075A6 (en) 3-(2-Haloalkyl)-1,4-oxathiins and 2-(2-haloalkyl)-1,4-dithiins, and treatment of leukemia and tumors therewith
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions
ES8100304A1 (en) Process for producing eburnane derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204